Fundamental dimension Equity attribute | BICTFLeader $0.010.00% Cap $379.1KP/E -0.1x QuantScore38/100 | BIOAFPeer $0.00010.00% Cap $7.94KP/E -0.1x QuantScore23/100 | CDXIPeer $0.00010.00% Cap $80P/E -0.0x QuantScore37/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
82/100 |
51/100 |
65/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 0/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 20/100 | 20/100 | 23/100 |
Growth Revenue / earnings growth & margins | 50/100 | 20/100 | 26/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.1x | -0.1x | -0.0x |
Forward P/E (next FY) | — | -0.0x | — |
EV / EBITDA (TTM) | -8.6x | -0.2x | -1.8x |
Price / Sales | — | 10.5x | 0.0x |
Price / Free Cash Flow | -11.0x | -0.1x | -0.0x |
PEG ratio | -0.00 | -0.01 | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 2 / 9 | 2 / 9 | 3 / 9 |
Altman Z-Score | -1180.44 (Distress) | -42.04 (Distress) | -91.48 (Distress) |
Total debt / equity | -0.10 | -0.99 | -0.47 |
Quick ratio | 0.0x | 0.7x | 0.0x |
Interest coverage | -93.0x | -7.5x | -1.3x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | -99.1% | -24.2% |
Net income growth YoY | +60.8% | -523.8% | +0.7% |
Gross margin (TTM) | 0.0% | -45.6% | 63.6% |
Operating margin (FY) | — | -12784.5% | -568.3% |
FCF margin (FY) | — | -9636.9% | -335.1% |
5. Trailing price performancePrice change over period |
1M return | 0.0% | +0.0% | +0.0% |
3M return | 0.0% | +0.0% | +0.0% |
6M return | 0.0% | +0.0% | +0.0% |
Year to date | 0.0% | -50.0% | +0.0% |
1Y return | 0.0% | -50.0% | +0.0% |
3Y return | -98.4% | -98.0% | -50.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.0007 -106.8% premium | $-0.0125 -12625.3% premium | $-9.67 -9674404.4% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |